F. Ratjen and G. Döring, Cystic fibrosis, The Lancet, vol.361, issue.9358, pp.681-689, 2003.
DOI : 10.1016/S0140-6736(03)12567-6

URL : https://hal.archives-ouvertes.fr/hal-01361411

M. Stutts, C. Canessa, J. Olsen, M. Hamrick, and J. Cohn, CFTR as a cAMP-dependent regulator of sodium channels, Science, vol.261, issue.2, pp.847-850, 1995.
DOI : 10.1089/hum.1992.3.3-253

M. Amaral, CFTR and chaperones, Journal of Molecular Neuroscience, vol.2323, pp.41-481, 2004.
DOI : 10.1385/jmn:23:1-2:041

R. Robert, G. Carlile, J. Liao, H. Balghi, and P. Lesimple, Correction of the ??Phe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine, Molecular Pharmacology, vol.77, issue.6, pp.922-930, 2010.
DOI : 10.1124/mol.109.062679

F. Van-goor, K. Straley, D. Cao, J. González, and S. Hadida, Rescue of ?F508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules, AJP: Lung Cellular and Molecular Physiology, vol.290, issue.6, pp.1117-1130, 2005.
DOI : 10.1152/ajplung.00169.2005

J. Colas, G. Faure, E. Saussereau, S. Trudel, and W. Rabeh, Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect, Human Molecular Genetics, vol.21, issue.3, 2011.
DOI : 10.1093/hmg/ddr496

A. Tamanini, M. Borgatti, A. Finotti, L. Piccagli, and V. Bezzerri, Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function, AJP: Lung Cellular and Molecular Physiology, vol.300, issue.3, pp.380-390, 2010.
DOI : 10.1152/ajplung.00129.2010

B. Grubb and R. Boucher, Pathophysiology of gene-targeted mouse models for cystic fibrosis, Physiological Reviews, vol.79, p.193, 1999.

C. Goubau, M. Wilschanski, V. Skalická, P. Lebecque, and K. Southern, Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis, Thorax, vol.64, issue.8, pp.683-691, 2009.
DOI : 10.1136/thx.2008.104752

I. Sermet-gaudelus, K. Boeck, G. Casimir, F. Vermeulen, and T. Leal, Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.182, issue.10, 2010.
DOI : 10.1164/rccm.201001-0137OC

F. Accurso, S. Rowe, J. Clancy, M. Boyle, and J. Dunitz, Mutation, New England Journal of Medicine, vol.363, issue.21, pp.1991-2003, 2010.
DOI : 10.1056/NEJMoa0909825

M. Cartiera, E. Ferreira, C. Caputo, M. Egan, and M. Caplan, Partial Correction of Cystic Fibrosis Defects with PLGA Nanoparticles Encapsulating Curcumin, Molecular Pharmaceutics, vol.7, issue.1, pp.86-93, 2010.
DOI : 10.1021/mp900138a

B. Lubamba, J. Lebacq, P. Lebecque, R. Vanbever, and A. Leonard, Airway Delivery of Low-Dose Miglustat Normalizes Nasal Potential Difference in F508del Cystic Fibrosis Mice, American Journal of Respiratory and Critical Care Medicine, vol.179, issue.11, pp.1022-1028, 2009.
DOI : 10.1164/rccm.200901-0049OC

P. Barker, Ion Transport across Cystic Fibrosis Nasal Epithelium, American Journal of Respiratory and Critical Care Medicine, vol.171, issue.8, pp.868-871, 2005.
DOI : 10.1164/rccm.200311-1508OC

K. Brady, T. Kelley, and M. Drumm, Examining basal chloride transport using the nasal potential difference response in a murine model, Am J Physiol Lung Cell Mol Physiol, vol.281, pp.1173-1179, 2001.

B. Grubb, T. Rogers, R. Boucher, and L. Ostrowski, Ion transport across CF and normal murine olfactory and ciliated epithelium, AJP: Cell Physiology, vol.296, issue.6, p.1301, 2009.
DOI : 10.1152/ajpcell.00578.2008

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692423

B. Lubamba, H. Lecourt, J. Lebacq, P. Lebecque, D. Jonge et al., Preclinical Evidence that Sildenafil and Vardenafil Activate Chloride Transport in Cystic Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.5, pp.506-515, 2008.
DOI : 10.1164/rccm.200703-344OC

U. Griesenbach, S. Smith, R. Farley, C. Singh, and A. Ewfw, Validation of Nasal Potential Difference Measurements in Gut-Corrected CF Knockout Mice, American Journal of Respiratory Cell and Molecular Biology, vol.39, issue.4, pp.490-496, 2008.
DOI : 10.1165/rcmb.2007-0385OC

D. Salinas, N. Pedemonte, C. Muanprasat, W. Finkbeiner, and D. Nielson, CFTR involvement in nasal potential differences in mice and pigs studied using a thiazolidinone CFTR inhibitor, AJP: Lung Cellular and Molecular Physiology, vol.287, issue.5, p.936, 2004.
DOI : 10.1152/ajplung.00354.2003

D. Parsons, P. Hopkins, A. Bourne, R. Boucher, and A. Martin, Airway gene transfer in mouse nasal-airways: importance of identification of epithelial type for assessment of gene transfer, Gene Therapy, vol.7, issue.21, pp.1810-1815, 2000.
DOI : 10.1038/sj.gt.3301317

I. Sermet-gaudelus, E. Girodon, D. Roussel, E. Deneuville, and S. Bui, Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis, Thorax, vol.65, issue.6, pp.539-544, 2010.
DOI : 10.1136/thx.2009.123422

J. Bland and D. Altman, Statistical methods for assessing agreement between two methods of clinical measurement, International Journal of Nursing Studies, vol.47, issue.8, pp.307-310, 1986.
DOI : 10.1016/j.ijnurstu.2009.10.001

Z. Zhang, S. Zeltwanger, and N. Mccarty, Direct Comparison of NPPB and DPC as Probes of CFTR Expressed in Xenopus Oocytes, Journal of Membrane Biology, vol.175, issue.1, pp.35-52, 2000.
DOI : 10.1007/s002320001053

E. Schwiebert, M. Morales, S. Devidas, M. Egan, and W. Guggino, Chloride channel and chloride conductance regulator domains of CFTR, the cystic fibrosis transmembrane conductance regulator, Proceedings of the National Academy of Sciences, vol.92, issue.15, pp.2674-2679, 1998.
DOI : 10.1073/pnas.92.15.6832

E. Schwiebert, T. Flotte, G. Cutting, and W. Guggino, Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents, American Journal of Physiology -Cell Physiology, vol.266, pp.1464-1477, 1994.

E. Bruscia, J. Price, E. Cheng, S. Weiner, and C. Caputo, Assessment of cystic fibrosis transmembrane conductance regulator (CFTR) activity in CFTR-null mice after bone marrow transplantation, Proceedings of the National Academy of Sciences, vol.27, issue.1, pp.2965-2970, 2006.
DOI : 10.1016/S0301-472X(99)00032-6

M. Egli, H. Duplain, M. Lepori, S. Cook, and P. Nicod, Defective respiratory amiloride-sensitive sodium transport predisposes to pulmonary oedema and delays its resolution in mice, The Journal of Physiology, vol.271, issue.3, pp.857-865, 2004.
DOI : 10.1111/j.1469-7793.2000.00771.x

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1665279

B. Grubb, S. Gabriel, A. Mengos, M. Gentzsch, and S. Randell, SERCA Pump Inhibitors Do Not Correct Biosynthetic Arrest of ?F508 CFTR in Cystic Fibrosis, American Journal of Respiratory Cell and Molecular Biology, vol.34, issue.3, pp.355-363, 2006.
DOI : 10.1165/rcmb.2005-0286OC

P. Middleton and H. House, Measurement of airway ion transport assists the diagnosis of cystic fibrosis, Pediatric Pulmonology, vol.2, issue.8, pp.789-795, 2010.
DOI : 10.1136/bmj.313.7059.744

J. Sorensen, The Use and Misuse of the Coefficient of Variation in Organizational Demography Research, Sociological Methods & Research, vol.30, issue.4, pp.475-491, 2002.
DOI : 10.1177/0049124102030004001